Atherosclerosis, a condition in which plaque accumulates on the inner wall of arteries, is often recognized as a precursor to cardiovascular diseases (CVDs), the most common causes of death in the US. Optical Coherence Tomography (OCT) is an intravascular optical diagnosis tool, which can be used to obtain high resolution morphological images of atherosclerotic plaque. However, atherosclerotic plaque components, such as macrophages, can be misclassified due to their signal similarities to fibrin accumulations, cholesterol crystals and microcalcifications. To overcome these challenges, we develop a biocompatible contrast agent to enhance molecular imaging of a Pump-Probe OCT (PPOCT) system. Methylene blue (MB) was encapsulated into poly lactic-co-glycolic acid (PLGA) particles by an emulsion/solvent evaporation technique. Fabrication parameters were controlled to synthesize particles with desired properties such as: size, encapsulation efficiency, degradation rate, and particle surface functionalization. The encapsulation of MB protects it from the enzymatic reduction to leuco-methylene blue (92.8 % protection), and reduces the singlet oxygen generation by the excited MB molecules by 78.3%. Likewise, the PLGA shells improve the OCT signal by enhancing the scattering of light. The surface of particles was modified with ligands that can target molecular biomarkers involved in atherosclerotic plaque formation such as vascular cell adhesion molecules (VCAM-1) and apoptotic macrophages. This modification is expected to enhance tissue selectivity, provides detailed information on the local biochemistry and yields visualization of pathological processes. PLGA-based contrast agents were tested in human postmortem artery sections to study particles permeability as a function of particle size and its molecular selectivity.
Jorge Palma-Chavez, Wihan Kim, Brian E. Applegate, Phapanin P. Charoenphol, and Javier A. Jo, "Contrast enhancement of pump-probe optical coherence tomography (PP-OCT) based molecular imaging using methylene blue loaded PLGA particles (Conference Presentation)," Proc. SPIE 10508, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications X, 105080F (Presented at SPIE BiOS: January 30, 2018; Published: 15 March 2018); https://doi.org/10.1117/12.2287469.5752179468001.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the proceedings. They include the speaker's narration with video of the slides and animations. Most include full-text papers. Interactive, searchable transcripts and closed captioning are now available for most presentations.
Search our growing collection of more than 27,500 conference presentations, including many plenaries and keynotes.